Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Iron Supplementation in CABG
NCT04061655Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2019
- Primary completion
- Jan 2020
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ferric derisomaltose in postoperative anemia (2 arms), sponsored by Ain Shams University. Primary endpoint: Haemoglobin Concentration Change. Started Sep 2019; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
postoperative anemia
Beyond the preview
Go deeper on NCT04061655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04061655.